HNVR
Hanover Bancorp, Inc.
HNVR has slightly lower modeled downside risk, despite its lower overall score.
MS
Morgan Stanley
MS has the edge over HNVR overall, supported by stronger fundamentals and stronger valuation.
HNVR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
HNVR's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like HNVR.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
HNVR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.7x | $9.35 | -58% |
| Forward | 7.9x | $22.23 | — |
| Fair | 11x | $16.03 | -28% |
| Current | 16x | $22.23 | — |
| Expensive | 17x | $24.34 | +9.5% |
Historical ranges are pointers, not guarantees.
HNVR's PE is in its expensive range at 16x. If earnings grow as analysts expect, today's price would be 7.9x next year's earnings, in its cheap range.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS has the edge over HNVR in the historical PE scenario, which offers more potential upside but is not a forecast.
HNVR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for HNVR, with profitability improving.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
HNVR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.81 | +101% |
| Q3 2026 | $1.40 | -7.9% |
| Q2 2026 | $1.27 | -17% |
| Q1 2026 | $1.05 | -20% |
| Q4 2025 | $1.00 | -40% |
| Q3 2025 | $1.52 | -7.9% |
| Q2 2025 | $1.53 | -7.3% |
| Q1 2025 | $1.31 | -33% |
| Q4 2024 | $1.66 | -9.8% |
HNVR's earnings per share have fallen from their peak: $1.40 over the past year, against $4.43 in mid-2022.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over HNVR on earnings, with more consistent year-over-year improvement.
HNVR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19.3M | +7.1% |
| Q2 2026 | $19.6M | +6.6% |
| Q1 2026 | $19.1M | +4.1% |
| Q4 2025 | $18.6M | +3.3% |
| Q3 2025 | $18M | +5.6% |
| Q2 2025 | $18.4M | +8.8% |
| Q1 2025 | $18.4M | +11% |
| Q4 2024 | $18M | +13% |
HNVR's revenue has grown year over year for 11 quarters in a row: $19M last quarter, up 7.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | +4.1 points |
| Q2 2026 | 28% | +9.3 points |
| Q1 2026 | 16% | +5.9 points |
| Q4 2025 | 0.7% | -28 points |
| Q3 2025 | 26% | -1.1 points |
| Q2 2025 | 18% | +12 points |
| Q1 2025 | 9.6% | -23 points |
| Q4 2024 | 29% | -2.8 points |
HNVR's operating margin was 30% last quarter, up 4.1 points from the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over HNVR on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over HNVR on profitability, with a higher operating margin.
HNVR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $14.7M | +504% |
| Q2 2026 | $18M | +$20.2M |
| Q1 2026 | -$2.7M | -169% |
| Q4 2025 | $8M | +278% |
| Q3 2025 | $2.4M | +18% |
| Q2 2025 | -$2.2M | +$708K |
| Q1 2025 | $3.9M | +18% |
| Q4 2024 | $2.1M | -44% |
HNVR has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
HNVR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -106K shares |
| 1 year | -2.3% | -165K shares |
| 3 years | -0.1% | -6.1K shares |
| 5 years | +50% | +2.4M shares |
HNVR has the edge over MS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.2M |
| Q4 2025 | $1.3M |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has 1.6B diluted shares, down 1.5% from a year ago.
HNVR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.8x | Very low |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 4.5x | High |
| Q1 2025 | 5.4x | High |
| Q4 2024 | 4.2x | High |
HNVR has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
HNVR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.8 | Neutral |
| Stochastic | 21.6 | Neutral |
HNVR's weekly RSI is 36 (neutral) and its Stochastic is 22 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
HNVR PE vs Financial Services Sector
| Metric | HNVR | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 22% above |
| PE % | 78 | 60 | 18 pts above |
HNVR is trading at 16x earnings, a 22% premium to the Financial Services sector's median of 13x.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over HNVR on valuation relative to its sector.
HNVR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $24.0 | 7.4% below |
| 20 week MA | $25.2 | 12% below |
| 50 week MA | $23.7 | 6.3% below |
| 100 week MA | $23.1 | 3.8% below |
| 200 week MA | $20.6 | 8% above |
HNVR has fallen below most of its moving averages, though it's still 8% above its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over HNVR on trend strength, trading above more of its moving averages.
HNVR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $21.5 | $19.9 | -7.8% |
| 2023 | $19.9 | $17.6 | -11% |
| 2024 | $17.6 | $22.4 | +27% |
| 2025 | $22.4 | $23.4 | +4.7% |
| 2026 YTD | $23.4 | $22.2 | -5% |
HNVR has finished lower in two of the last four years. It's down 5% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over HNVR on returns for 2026, with the stronger performance.